// App-Quantinova.ai

8053 : Daratumumab-based therapies in patients with AL amyloidosis.

Researchers

Presenter

  • Jithma P. Abeykoon

Principal Investigators

  • Saurabh Zanwar

  • Shaji Kumar

  • Angela Dispenzieri

  • S. Vincent Rajkumar

  • Martha Lacy

  • David Dingli

  • Nelson Leung

  • Eli Muchtar

  • Wilson I. Gonsalves

  • Taxiarchis Kourelis

  • Francis Buadi

  • Robert A. Kyle

  • Morie A. Gertz

  • Prashant Kapoor

Medical Centers

  • Department of Internal Medicine, Mayo Clinic, Rochester, MN

  • Mayo Clinic, Rochester, MN

  • Mayo Clinic, Division of hematology, Rochester, MN

  • Division of Medical Oncology, Mayo Clinic, Rochester, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Dihydrolipoamide Branched Chain Transacylase E2

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Pomalidomide

  • CC-4047

  • Lenalidomide

  • daratumumab Intravenous

  • Bortezomib

  • Sparsentan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved